Funding Announcements

"Our vision is to be at the forefront of cancer drug testing and provide personalised medicine testing to every individual suffering from cancer to improve their treatment and chance of survival. Working with global partners, leading pharma companies, surgeons, pathologists, and clinicians, Carcinotech aims to accelerate oncology drug development significantly."

"Supply interruptions cost utility companies billions of pounds each year, not only in trying to repair and restore supplies but also paying compensation to customers. Construction work is a key cause of disruption and the situation is likely to get worse in the future if planning laws are relaxed. Our systems help them make the most of the available data and take a pro-active approach to identifying and tackling potential hazards. The new system will be the most powerful to date and could help companies to dramatically reduce downtime, regulatory fines and their environmental impact."

"We have achieved a lot in a relatively short period but having the support of BGF will enable us to significantly accelerate all parts of our business and to firmly establish ourselves as the global leader in the next generation of market intelligence on the next generation of consumers. Having the backing of an experienced investor such as BGF, is an exciting validation of our commitment to reaching this goal."

"The appointment of our first Non-Executive is a testament to our commitment to assembling an expert leadership team,"